Get started
J B CHEMICALS AND PHARMAJ B CHEMICALS AND PHARMAJ B CHEMICALS AND PHARMA

J B CHEMICALS AND PHARMA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast

JBCHEPHARM chart


Full chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪294.85 B‬INR
Dividend yield (indicated)
0.65%
Price to earnings Ratio (TTM)
50.35
Basic EPS (TTM)
37.85INR
Net income (FY)
‪5.53 B‬INR
Revenue (FY)
‪34.68 B‬INR
Shares float
‪71.14 M‬
Beta (1Y)
0.07

About J B CHEMICALS AND PHARMA


Sector
Health Technology
CEO
Nikhil Ashok Kumar Chopra
Headquarters
Mumbai
Website
jbpharma.com
Employees (FY)
‪7.39 K‬
Founded
1976
ISIN
INE572A01036
FIGI
BBG000CTJJ73
J.B. Chemicals & Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and trade of pharmaceutical products. It operates through the following business units: India; Russia & CIS; Global; Contrast Media; API; and Business Development. The India business unit produces medicine for gastro, cardiac, and pain management. The Russia and CIS business unit markets and sells over the counter and prescription drugs. The Global business unit commercializes generic branded medicines. The Contrast Media business unit offers radiopaque substances such as lohexol, lopamidol, diatrazoic acid, gadopentatic acid, and iodixanol. The API business unit caters active pharmaceutical ingredients which includes atenelol, clinidipine, diclofenac acid, diclofenac potassium, nifedipine, and gadopentatic acid. The Business Development business unit deals with contract manufacturing, joint ventures, marketing partners, in-licensing of products, and distribution network. The company was founded by Jyotindra Bhagwanlal Mody on December 18, 1976 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

News



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


The current price of JBCHEPHARM is 1,897.25 INR — it has increased by 0.57% in the past 24 hours. Watch J B CHEMICALS AND PHARMA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange J B CHEMICALS AND PHARMA stocks are traded under the ticker JBCHEPHARM.
JBCHEPHARM stock has fallen by −0.13% compared to the previous week, the month change is a −2.34% fall, over the last year J B CHEMICALS AND PHARMA has showed a 29.06% increase.
We've gathered analysts' opinions on J B CHEMICALS AND PHARMA future price: according to them, JBCHEPHARM price has a max estimate of 2,255.00 INR and a min estimate of 1,651.00 INR. Watch JBCHEPHARM chart and read a more detailed J B CHEMICALS AND PHARMA stock forecast: see what analysts think of J B CHEMICALS AND PHARMA and suggest that you do with its stocks.
JBCHEPHARM reached its all-time high on Aug 16, 2024 with the price of 2,030.00 INR, and its all-time low was 7.15 INR and was reached on Feb 9, 1999. View more price dynamics on JBCHEPHARM chart.
See other stocks reaching their highest and lowest prices.
JBCHEPHARM stock is 1.81% volatile and has beta coefficient of 0.07. Track J B CHEMICALS AND PHARMA stock price on the chart and check out the list of the most volatile stocks — is J B CHEMICALS AND PHARMA there?
Today J B CHEMICALS AND PHARMA has the market capitalization of ‪294.85 B‬, it has decreased by −1.04% over the last week.
Yes, you can track J B CHEMICALS AND PHARMA financials in yearly and quarterly reports right on TradingView.
J B CHEMICALS AND PHARMA is going to release the next earnings report on Nov 7, 2024. Keep track of upcoming events with our Earnings Calendar.
JBCHEPHARM net income for the last quarter is ‪1.77 B‬ INR, while the quarter before that showed ‪1.26 B‬ INR of net income which accounts for 40.16% change. Track more J B CHEMICALS AND PHARMA financial stats to get the full picture.
J B CHEMICALS AND PHARMA dividend yield was 0.74% in 2023, and payout ratio reached 34.35%. The year before the numbers were 0.90% and 33.49% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 22, 2024, the company has ‪7.39 K‬ employees. See our rating of the largest employees — is J B CHEMICALS AND PHARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. J B CHEMICALS AND PHARMA EBITDA is ‪9.45 B‬ INR, and current EBITDA margin is 25.76%. See more stats in J B CHEMICALS AND PHARMA financial statements.
Like other stocks, JBCHEPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade J B CHEMICALS AND PHARMA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So J B CHEMICALS AND PHARMA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating J B CHEMICALS AND PHARMA stock shows the buy signal. See more of J B CHEMICALS AND PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.